“Clinical Response in Plaque Psoriasis Patients Switching from Etanercept to Certolizumab Pegol in a Phase 3, Randomized, Controlled Study”, J of Skin, vol. 2, p. S86, Dec. 2018, doi: 10.25251/skin.2.supp.87.